Hepatitis A Vaccine
For more information, see Hepatitis A ACIP Vaccine Recommendations.
The HepA vaccine is a routine childhood vaccination (see Table: Recommended Immunization Schedule for Ages 0–6 yr).
HepA vaccine is indicated when any of the following is present:
A desire for protection from hepatitis A in people not previously vaccinated
Travel to or work in endemic areas
Occupational exposure (eg, working with primates infected with hepatitis A virus [HAV] or HAV in a research laboratory)
Sex between men
Use of illicit drugs (injected or not), such as methamphetamine
Treatment with clotting factor concentrates
A chronic liver disorder
Anticipated close personal contact (eg, as members of the household or as regular babysitters) with an adopted child during the first 60 days after the child's arrival in the US from an endemic area
The combination HepA and HepB vaccine can be used in people ≥ 18 yr who have indications for either hepatitis A or hepatitis B vaccine and who have not been previously vaccinated with one of the vaccine components.
The dose is 0.5 mL IM up to age 18 yr or 1 mL IM for adults (age ≥ 19 yr).
Children are given a 2-dose series typically at age 12 to 23 mo and 6 to 18 mo after the 1st dose.
Adults are given the vaccine in a 2-dose series: at 0 mo and at 6 to 18 mo.
Or adults may be given the combination HepA and HepB vaccine on a 3-dose schedule: at 0, 1, and 6 mo. The 1st and 2nd doses should be separated by ≥ 4 wk, and the 2nd and 3rd doses should be separated by ≥ 5 mo. Alternatively, the vaccine may be given on a 4-dose schedule: on days 0, 7, and 21 to 30, followed by a booster 12 mo after the 1st dose.
As soon as an adoption of a child from an endemic area is planned, close contacts should be given the 1st dose of the 2-dose HepA vaccine series, ideally ≥ 2 wk before the adopted child arrives.
Drug NameSelect Trade